Synapse

← Molecular Biomedicine

Papers in Molecular Biomedicine

Page 1 · newest first

  1. Dynamic monitoring of cell-free DNA levels in glioblastoma patients: a longitudinal study on treatment responseMolecular Biomedicine · 2026
  2. The hepatic immune niche in liver diseases and transplantation: from homeostasis to therapeutic targetingMolecular Biomedicine · 2026
  3. The intracellular region of truncated neurotrophin receptor TrkB-T1 is sufficient to promote brain glial reactivity, neuroinflammation and neurotoxicityMolecular Biomedicine · 2026
  4. Osteoarthritis: epidemiology, risk factors, molecular pathogenesis, therapeutic progress, and future perspectivesMolecular Biomedicine · 2026
  5. Advanced biomedical materials and drug delivery systems for gastrointestinal applications: current understanding and future perspectivesMolecular Biomedicine · 2026
  6. GLP-1/GLP-1R signalling in infectious diseases: basic biology, immunometabolic mechanisms, and therapeutic translationMolecular Biomedicine · 2026
  7. Preoperative discrimination of malignant and benign ovarian masses using cfDNA fragmentomics and serum biomarkersMolecular Biomedicine · 2026
  8. Sitagliptin ameliorates radiation-induced oral mucositis by inhibiting oxidative damage and inflammatory response via TLR2/MyD88/NF-κB signaling pathwayMolecular Biomedicine · 2026
  9. Temporally evolving neuronal remodeling via the CTNNB1–NRG3–ERBB4 axis drives therapy resistance in glioblastomaMolecular Biomedicine · 2026
  10. Aerobic exercise preconditioning inhibits GSDME-dependent pyroptosis in myocardial ischemia–reperfusion injury through IGFBP2-AKT-PDCD4 signalingMolecular Biomedicine · 2026
  11. Super-enhancers: regulatory mechanisms, biological functions, diseases, and therapeutic targetsMolecular Biomedicine · 2026
  12. Non-thermal argon plasma therapy alleviates atopic dermatitis by reducing keratinocyte oxidative stressMolecular Biomedicine · 2026
  13. Syncytiotrophoblast differentiation defects drive ER stress and reprogram placental PSG1 glycosylation in preeclampsiaMolecular Biomedicine · 2026
  14. Cat eye syndrome chromosome region, candidate 1 is a novel prognostic biomarker in hypertrophic cardiomyopathyMolecular Biomedicine · 2026
  15. Chemical genetic screens combine target dependence with efficacy: discovery of a MAP3K1 degrader (HBC-8) with anticancer activitiesMolecular Biomedicine · 2026
  16. Effects of SGLT2 inhibition on cardiac remodeling and heart failure development in aortic stenosis ratsMolecular Biomedicine · 2026
  17. Bone morphogenetic protein 12: a novel target for cardiovascular diseaseMolecular Biomedicine · 2026
  18. Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and agingMolecular Biomedicine · 2026
  19. Transcriptional and phenotypic alterations of regulatory and effector T cells in type 1 diabetes mellitusMolecular Biomedicine · 2026
  20. Circadian rhythms in health and diseaseMolecular Biomedicine · 2026
  21. Citrullinated histone H3 and elevated polyamine metabolism gene expression in peripheral blood polymorphonuclear leukocytes as biomarkers for poor immunotherapy response in cancer patientsMolecular Biomedicine · 2026
  22. Ferroptosis in health and diseaseMolecular Biomedicine · 2026
  23. The sirtuin family: from mechanisms to therapyMolecular Biomedicine · 2026
  24. EZH2 coordinates inflammatory and pain-associated pathways across joint compartments in osteoarthritisMolecular Biomedicine · 2026
  25. Aquaporin water channels: distribution, physiology, pathophysiology, and relevance as therapeutic targetsMolecular Biomedicine · 2026
  26. Epigenetic regulatory networks in the pathogenesis and treatment of osteoporosis subtypesMolecular Biomedicine · 2026
  27. Lipid nanoparticle-mediated transcription factor EB mRNA delivery for the treatment of metabolic dysfunction-associated steatotic liver diseaseMolecular Biomedicine · 2026
  28. RCCD1-JMJD5 coordinate histone demethylation to promote platinum resistance in non-small cell lung cancer via FN1-mediated epithelial–mesenchymal transitionMolecular Biomedicine · 2026
  29. Lysine-specific demethylase 1 (LSD1) regulates macrophage plasticity and immune checkpoint expression in colorectal liver metastasesMolecular Biomedicine · 2026
  30. Autism: epidemiology, genetics, molecular mechanisms, clinical features, diagnosis, and managementMolecular Biomedicine · 2026
  31. Macrophage interferon regulatory factor 7 aggravates the progression of metabolic dysfunction-associated steatohepatitisMolecular Biomedicine · 2026
  32. Curcumin analogue FLLL32 induces ferroptosis by targeting the STAT3-GPX4/SLC40A1 axis in colorectal cancerMolecular Biomedicine · 2026
  33. Curcumin alleviates metabolic dysfunction-associated steatotic liver disease via gut microbiota-dependent epigenetic alterationsMolecular Biomedicine · 2026
  34. Synthetic Notch CD123 and CLL1 chimeric antigen receptor T-cells (CAR-T) target acute myeloid leukemia and reduce off-tumor effects associated with CLL1 CAR-T cellsMolecular Biomedicine · 2026
  35. Docosahexaenoic acid remodels lipid composition of lipid rafts and mitochondrial function in ApoE4/4 mouse brain: a multi-omic investigationMolecular Biomedicine · 2026
  36. Colitis-associated colorectal carcinogenesis: molecular mechanisms and therapeutic potentialMolecular Biomedicine · 2026
  37. Alistipes-derived monomethyl branched-chain fatty acid iso-15:0 suppresses hepatocellular carcinoma progression by inhibiting Gβγ/PI3K/AKT signalingMolecular Biomedicine · 2026
  38. Epigenetically silencing gluconeogenic enzyme PCK1 by EZH2 promotes renal tubulointerstitial fibrosisMolecular Biomedicine · 2026
  39. Mechanotransduction through oxidative stress upregulates circLyst to drive vascular remodeling in hypertensive humans and rodentsMolecular Biomedicine · 2026
  40. Renal stress-associated extracellular vesicle signaling linked to lysosomal cathepsin D and NEK7–NLRP3 neuroinflammationMolecular Biomedicine · 2026
  41. The ubiquitin–proteasome system and proteostasis in the cochlea and sensorineural hearing disordersMolecular Biomedicine · 2026
  42. Suppressor with morphogenetic effect on genitalia 7 (SMG7) drives hepatocellular carcinoma progression through context-dependent nonsense-mediated decay (NMD) dysregulationMolecular Biomedicine · 2026
  43. CUE domain-containing 2 promotes diffuse large B-cell lymphoma progression via PP2A-B55β degradation and shapes macrophage-mediated immune responsesMolecular Biomedicine · 2026
  44. Pregnancy-related disorders: molecular mechanisms and managementMolecular Biomedicine · 2026
  45. CD8⁺ T Cell infiltration and spatial organization in cancer: mechanisms, barriers, and therapeutic strategiesMolecular Biomedicine · 2026
  46. Cerebral cavernous malformations: epidemiology, molecular pathogenesis, diagnosis and therapyMolecular Biomedicine · 2026
  47. Recent advances in antituberculosis drugs and therapeutics: from mechanistic breakthroughs to clinical translationMolecular Biomedicine · 2026
  48. H2A.J is an epigenetic driver of IL-17-associated inflammation in TH17 cells and keratinocytesMolecular Biomedicine · 2026
  49. An inducible co-stimulator ligand (ICOSL)-based peptide therapy for proteinuric kidney diseases targeting αvβ3 integrinMolecular Biomedicine · 2026
  50. Lactate-induced MBD2 K186 lactylation promotes YAP1-dependent myofibroblast-like remodeling of Müller cells in diabetic retinopathyMolecular Biomedicine · 2026